Skip to content
healthcare.dev
Get a free key

My After Plan

NDC 51660-098, levonorgestrel, tablet, from OHM LABORATORIES INC.

Product NDC
51660-098
Status
Listed
Labeler
OHM LABORATORIES INC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA207660
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51660-098 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LEVONORGESTREL1.5 mg/1

Pharmacologic classes

Inhibit Ovum Fertilization [PE]; Progesterone Congeners [CS]; Progesterone Congeners [CS]; Progestin [EPC]; Progestin-containing Intrauterine System [EPC]

Package NDCNDC-11Package
51660-098-11516600098111 BLISTER PACK in 1 CARTON (51660-098-11) / 1 TABLET in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 51660-098 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51660-098 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51660-098. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.